Cingulate Historical Balance Sheet

CING Stock  USD 4.76  0.22  4.42%   
Trend analysis of Cingulate balance sheet accounts such as Short Long Term Debt Total of 3 M, Other Current Liabilities of 1.2 M or Total Current Liabilities of 12.3 M provides information on Cingulate's total assets, liabilities, and equity, which is the actual value of Cingulate to its prevalent stockholders. By breaking down trends over time using Cingulate balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Cingulate latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Cingulate is a good buy for the upcoming year.

Cingulate Inventory

(17,656.06)

  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cingulate. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more detail on how to invest in Cingulate Stock please use our How to Invest in Cingulate guide.

About Cingulate Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Cingulate at a specified time, usually calculated after every quarter, six months, or one year. Cingulate Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Cingulate and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Cingulate currently owns. An asset can also be divided into two categories, current and non-current.

Cingulate Balance Sheet Chart

At this time, Cingulate's Current Deferred Revenue is most likely to increase significantly in the upcoming years. The Cingulate's current Net Debt is estimated to increase to about 3.7 M, while Short and Long Term Debt Total is projected to decrease to roughly 3 M.

Total Assets

Total assets refers to the total amount of Cingulate assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Cingulate books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Cingulate balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Cingulate are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.
Most accounts from Cingulate's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Cingulate current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cingulate. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more detail on how to invest in Cingulate Stock please use our How to Invest in Cingulate guide.At this time, Cingulate's Current Deferred Revenue is most likely to increase significantly in the upcoming years. The Cingulate's current Net Debt is estimated to increase to about 3.7 M, while Short and Long Term Debt Total is projected to decrease to roughly 3 M.
 2022 2023 2024 2025 (projected)
Short and Long Term Debt Total5.5M3.1M3.6M3.0M
Total Assets11.4M3.5M4.0M3.8M

Cingulate balance sheet Correlations

-0.170.02-0.320.040.310.14-0.03-0.97-0.510.990.07-0.490.990.98-0.36-0.33-0.13-0.290.70.33-0.40.730.290.99-0.33
-0.170.440.66-0.940.62-0.610.10.40.33-0.18-0.62-0.71-0.18-0.33-0.46-0.49-0.59-0.60.520.540.710.170.52-0.11-0.48
0.020.440.78-0.180.87-0.890.570.020.630.1-0.91-0.110.1-0.09-0.88-0.89-0.91-0.850.270.910.770.620.90.11-0.49
-0.320.660.78-0.380.74-0.970.320.40.9-0.24-0.95-0.11-0.25-0.46-0.65-0.68-0.88-0.810.250.740.860.390.78-0.22-0.65
0.04-0.94-0.18-0.38-0.430.32-0.02-0.280.00.070.350.850.070.170.320.330.370.41-0.61-0.34-0.43-0.07-0.290.00.33
0.310.620.870.74-0.43-0.860.26-0.190.480.37-0.89-0.480.370.16-0.88-0.89-0.94-0.960.630.990.720.810.960.4-0.79
0.14-0.61-0.89-0.970.32-0.86-0.33-0.22-0.840.060.990.140.060.290.760.780.940.89-0.31-0.87-0.88-0.56-0.890.050.71
-0.030.10.570.32-0.020.26-0.330.030.170.01-0.390.020.01-0.04-0.65-0.63-0.45-0.370.110.370.120.190.390.010.23
-0.970.40.020.4-0.28-0.19-0.220.030.5-0.97-0.150.26-0.97-0.990.270.250.040.17-0.51-0.230.49-0.68-0.2-0.950.23
-0.510.330.630.90.00.48-0.840.170.5-0.43-0.790.32-0.43-0.6-0.37-0.4-0.66-0.55-0.130.50.760.20.56-0.43-0.51
0.99-0.180.1-0.240.070.370.060.01-0.97-0.43-0.01-0.451.00.97-0.43-0.4-0.21-0.350.70.4-0.350.790.361.0-0.38
0.07-0.62-0.91-0.950.35-0.890.99-0.39-0.15-0.79-0.010.21-0.010.210.820.840.970.93-0.39-0.9-0.84-0.61-0.92-0.030.71
-0.49-0.71-0.11-0.110.85-0.480.140.020.260.32-0.450.21-0.45-0.370.410.410.330.45-0.87-0.41-0.12-0.39-0.35-0.510.41
0.99-0.180.1-0.250.070.370.060.01-0.97-0.431.0-0.01-0.450.97-0.42-0.4-0.21-0.350.690.39-0.350.780.361.0-0.38
0.98-0.33-0.09-0.460.170.160.29-0.04-0.99-0.60.970.21-0.370.97-0.24-0.210.01-0.130.570.18-0.530.630.150.96-0.18
-0.36-0.46-0.88-0.650.32-0.880.76-0.650.27-0.37-0.430.820.41-0.42-0.241.00.920.92-0.63-0.93-0.49-0.8-0.91-0.440.54
-0.33-0.49-0.89-0.680.33-0.890.78-0.630.25-0.4-0.40.840.41-0.4-0.211.00.940.94-0.63-0.94-0.52-0.79-0.92-0.420.56
-0.13-0.59-0.91-0.880.37-0.940.94-0.450.04-0.66-0.210.970.33-0.210.010.920.940.98-0.55-0.96-0.72-0.74-0.95-0.230.74
-0.29-0.6-0.85-0.810.41-0.960.89-0.370.17-0.55-0.350.930.45-0.35-0.130.920.940.98-0.68-0.97-0.65-0.83-0.96-0.380.81
0.70.520.270.25-0.610.63-0.310.11-0.51-0.130.7-0.39-0.870.690.57-0.63-0.63-0.55-0.680.610.060.730.580.74-0.64
0.330.540.910.74-0.340.99-0.870.37-0.230.50.4-0.9-0.410.390.18-0.93-0.94-0.96-0.970.610.680.850.980.42-0.76
-0.40.710.770.86-0.430.72-0.880.120.490.76-0.35-0.84-0.12-0.35-0.53-0.49-0.52-0.72-0.650.060.680.230.68-0.32-0.53
0.730.170.620.39-0.070.81-0.560.19-0.680.20.79-0.61-0.390.780.63-0.8-0.79-0.74-0.830.730.850.230.830.79-0.76
0.290.520.90.78-0.290.96-0.890.39-0.20.560.36-0.92-0.350.360.15-0.91-0.92-0.95-0.960.580.980.680.830.38-0.75
0.99-0.110.11-0.220.00.40.050.01-0.95-0.431.0-0.03-0.511.00.96-0.44-0.42-0.23-0.380.740.42-0.320.790.38-0.4
-0.33-0.48-0.49-0.650.33-0.790.710.230.23-0.51-0.380.710.41-0.38-0.180.540.560.740.81-0.64-0.76-0.53-0.76-0.75-0.4
Click cells to compare fundamentals

Cingulate Account Relationship Matchups

Cingulate balance sheet Accounts

202020212022202320242025 (projected)
Total Assets5.8M22.9M11.4M3.5M4.0M3.8M
Short Long Term Debt Total2.0M881.1K5.5M3.1M3.6M3.0M
Other Current Liab1.4M896.9K894.6K2.0M2.3M1.2M
Total Current Liabilities3.4M1.2M7.0M10.2M11.8M12.3M
Total Stockholder Equity1.3M20.8M(69.4M)(6.9M)(6.2M)(6.5M)
Property Plant And Equipment Net4.0M4.0M3.5M2.9M2.6M3.0M
Net Debt849.0K(15.6M)170.0K3.1M3.5M3.7M
Accounts Payable975.1K264.7K762.4K5.2M6.0M6.3M
Cash1.2M16.5M5.4M52.4K60.3K57.3K
Non Current Assets Total4.0M4.0M3.5M3.1M2.8M3.0M
Non Currrent Assets Other0.0(1.4B)(5.9B)178.8K160.9K168.9K
Cash And Short Term Investments1.2M16.5M5.4M52.4K60.3K57.3K
Net Receivables151.8K690.2K234.4K14.6K13.2K12.5K
Liabilities And Stockholders Equity5.8M22.9M(61.9M)3.5M3.1M3.3M
Non Current Liabilities Total1.1M866.0K510.2K135.1K121.6K115.5K
Other Current Assets439.5K1.7M2.3M526.2K605.1K1.2M
Other Stockholder Equity31.0M72.6M73.3M86.1M99.0M57.9M
Total Liab4.5M2.0M7.5M10.4M11.9M6.4M
Total Current Assets1.8M18.9M7.9M578.6K665.4K632.1K
Short Term Debt936.6K15.1K5.4M3M3.5M2.1M

Currently Active Assets on Macroaxis

When determining whether Cingulate is a strong investment it is important to analyze Cingulate's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Cingulate's future performance. For an informed investment choice regarding Cingulate Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cingulate. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more detail on how to invest in Cingulate Stock please use our How to Invest in Cingulate guide.
You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cingulate. If investors know Cingulate will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cingulate listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(43.22)
Return On Assets
(1.04)
Return On Equity
(2.74)
The market value of Cingulate is measured differently than its book value, which is the value of Cingulate that is recorded on the company's balance sheet. Investors also form their own opinion of Cingulate's value that differs from its market value or its book value, called intrinsic value, which is Cingulate's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cingulate's market value can be influenced by many factors that don't directly affect Cingulate's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cingulate's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cingulate is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cingulate's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.